Romosozumab-Aqqg

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Very short-term monitoring of Romosozumab longitudinal effects in a cohort of postmenopausal women by means of Radiofrequency Echographic Multi-Spectrometry (REMS) technology.

Very short-term monitoring of Romosozumab longitudinal effects in a cohort of postmenopausal women by means of Radiofrequency Echographic Multi-Spectrometry (REMS) technology.

Journal: Aging clinical and experimental research

Published: March 13, 2026

Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product.

Similarity assessment of disulfide isoform profiles between the romosozumab biosimilar and the reference medicinal product.

Journal: Scientific reports

Published: January 09, 2026

A bone optimization rheumatology clinic increases anabolic bone agent use and reduces mechanical complications in adult spinal deformity surgery.

A bone optimization rheumatology clinic increases anabolic bone agent use and reduces mechanical complications in adult spinal deformity surgery.

Journal: Spine deformity

Published: September 04, 2025

Comparison table: Some drugs for postmenopausal osteoporosis.

Comparison table: Some drugs for postmenopausal osteoporosis.

Journal: The Medical letter on drugs and therapeutics

Published: July 09, 2024

Drugs for postmenopausal osteoporosis.

Drugs for postmenopausal osteoporosis.

Journal: The Medical letter on drugs and therapeutics

Published: July 09, 2024

Inhibition of both sclerostin and DKK1 results in novel skull findings in the rat and non-human primate that is not observed with inhibition of sclerostin alone.

Inhibition of both sclerostin and DKK1 results in novel skull findings in the rat and non-human primate that is not observed with inhibition of sclerostin alone.

Journal: Bone

Published: October 27, 2023

Bone union-promoting effect of romosozumab in an ovariectomized rat posterolateral lumbar fusion model.

Bone union-promoting effect of romosozumab in an ovariectomized rat posterolateral lumbar fusion model.

Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society

Published: August 03, 2023

Loss of Nmp4 enhances bone gain from sclerostin antibody administration.

Loss of Nmp4 enhances bone gain from sclerostin antibody administration.

Journal: Bone

Published: July 05, 2023

A breakthrough in the management of postmenopausal osteoporosis with very high fracture risk : romosozumab (Evenity®), a humanized monoclonal anti-sclerostin antibody

A breakthrough in the management of postmenopausal osteoporosis with very high fracture risk : romosozumab (Evenity®), a humanized monoclonal anti-sclerostin antibody

Journal: Revue medicale de Liege

Published: April 17, 2023

Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J).

Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J).

Journal: Pharmacoepidemiology and drug safety

Published: December 08, 2022

Osteoporosis: A Review of Novel Agents.

Osteoporosis: A Review of Novel Agents.

Journal: Orthopedic nursing

Published: November 22, 2022

Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient With Hypophosphatasia.

Romosozumab-aqqg in the Treatment of Osteoporosis in a Patient With Hypophosphatasia.

Journal: Journal of the Endocrine Society

Published: July 08, 2022

Showing 1-12 of 31

Last Updated: 06/30/2026